Home/Filings/4/0001209191-24-002928
4//SEC Filing

Adler Eric 4

Accession 0001209191-24-002928

CIK 0001907108other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 5:56 PM ET

Size

7.7 KB

Accession

0001209191-24-002928

Insider Transaction Report

Form 4
Period: 2024-02-02
Adler Eric
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2024-02-02+26,87526,875 total
  • Award

    Employee Stock Option (right to buy)

    2024-02-02+161,250161,250 total
    Exercise: $17.00Exp: 2034-02-01Common Stock (161,250 underlying)
Footnotes (2)
  • [F1]The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]25% of the shares underlying the option vest and become exercisable on February 2, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

Issuer

Lexeo Therapeutics, Inc.

CIK 0001907108

Entity typeother

Related Parties

1
  • filerCIK 0001994972

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:56 PM ET
Size
7.7 KB